{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T06:50:00Z","timestamp":1792133400902,"version":"4.4.0"},"reference-count":41,"publisher":"American Diabetes Association","issue":"7","license":[{"start":{"date-parts":[[2018,6,22]],"date-time":"2018-06-22T00:00:00Z","timestamp":1529625600000},"content-version":"vor","delay-in-days":50,"URL":"http:\/\/www.diabetesjournals.org\/content\/license"}],"funder":[{"DOI":"10.13039\/501100004191","name":"Novo Nordisk Foundation","doi-asserted-by":"publisher","award":["NNF15OC0016330"],"award-info":[{"award-number":["NNF15OC0016330"]}],"id":[{"id":"10.13039\/501100004191","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005416","name":"Research Council of Norway","doi-asserted-by":"publisher","award":["FRIMEDBIO 240788"],"award-info":[{"award-number":["FRIMEDBIO 240788"]}],"id":[{"id":"10.13039\/501100005416","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011199","name":"FP7 Ideas: European Research Council","doi-asserted-by":"publisher","award":["293574"],"award-info":[{"award-number":["293574"]}],"id":[{"id":"10.13039\/100011199","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R01-DK-055545"],"award-info":[{"award-number":["R01-DK-055545"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["P30-DK-036836"],"award-info":[{"award-number":["P30-DK-036836"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2018,7,1]]},"abstract":"<jats:p>Phosphatidylinositol 3-kinase (PI3K) plays a central role in insulin signaling, glucose metabolism, cell growth, cell development, and apoptosis. A heterozygous missense mutation (R649W) in the p85\u03b1 regulatory subunit gene of PI3K (PIK3R1) has been identified in patients with SHORT (Short stature, Hyperextensibility\/Hernia, Ocular depression, Rieger anomaly, and Teething delay) syndrome, a disorder characterized by postnatal growth retardation, insulin resistance, and partial lipodystrophy. Knock-in mice with the same heterozygous mutation mirror the human phenotype. In this study, we show that Pik3r1 R649W knock-in mice fed a high-fat diet (HFD) have reduced weight gain and adipose accumulation. This is accompanied by reduced expression of several genes involved in lipid metabolism. Interestingly, despite the lower level of adiposity, the HFD knock-in mice are more hyperglycemic and more insulin-resistant than HFD-fed control mice. Likewise, when crossed with genetically obese ob\/ob mice, the ob\/ob mice carrying the heterozygous R649W mutation were protected from obesity and hepatic steatosis but developed a severe diabetic state. Together, our data demonstrate a central role of PI3K in development of obesity and fatty liver disease, separating these effects from the role of PI3K in insulin resistance and the resultant hyperglycemia.<\/jats:p>","DOI":"10.2337\/db17-1509","type":"journal-article","created":{"date-parts":[[2018,5,3]],"date-time":"2018-05-03T16:05:39Z","timestamp":1525363539000},"page":"1297-1309","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":22,"title":["Mice Carrying a Dominant-Negative Human PI3K Mutation Are Protected From Obesity and Hepatic Steatosis but Not Diabetes"],"prefix":"10.2337","volume":"67","author":[{"given":"Marie H.","family":"Solheim","sequence":"first","affiliation":[{"name":"Joslin Diabetes Center and Harvard Medical School, Boston, MA"},{"name":"KG Jebsen Center for Diabetes Research, Department of Clinical Science, University of Bergen, Bergen, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathon N.","family":"Winnay","sequence":"additional","affiliation":[{"name":"Joslin Diabetes Center and Harvard Medical School, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thiago M.","family":"Batista","sequence":"additional","affiliation":[{"name":"Joslin Diabetes Center and Harvard Medical School, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Molven","sequence":"additional","affiliation":[{"name":"KG Jebsen Center for Diabetes Research, Department of Clinical Science, University of Bergen, Bergen, Norway"},{"name":"Gade Laboratory for Pathology, Department of Clinical Medicine, University of Bergen, Bergen, Norway"},{"name":"Department of Pathology, Haukeland University Hospital, Bergen, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e5l R.","family":"Nj\u00f8lstad","sequence":"additional","affiliation":[{"name":"KG Jebsen Center for Diabetes Research, Department of Clinical Science, University of Bergen, Bergen, Norway"},{"name":"Department of Pediatrics and Adolescent Medicine, Haukeland University Hospital, Bergen, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7583-9228","authenticated-orcid":false,"given":"C. Ronald","family":"Kahn","sequence":"additional","affiliation":[{"name":"Joslin Diabetes Center and Harvard Medical School, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","published-online":{"date-parts":[[2018,5,3]]},"reference":[{"key":"2022031300125947000_B1","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1038\/nrg1879","article-title":"The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism","volume":"7","author":"Engelman","year":"2006","journal-title":"Nat Rev Genet"},{"key":"2022031300125947000_B2","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s11010-007-9661-9","article-title":"Critical role of phosphoinositide 3-kinase cascade in adipogenesis of human mesenchymal stem cells","volume":"310","author":"Yu","year":"2008","journal-title":"Mol Cell Biochem"},{"key":"2022031300125947000_B3","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1006\/bbrc.1995.1965","article-title":"Wortmannin, a specific phosphatidylinositol 3-kinase inhibitor, inhibits adipocytic differentiation of 3T3-L1 cells","volume":"212","author":"Tomiyama","year":"1995","journal-title":"Biochem Biophys Res Commun"},{"key":"2022031300125947000_B4","doi-asserted-by":"crossref","first-page":"28945","DOI":"10.1074\/jbc.273.44.28945","article-title":"Posttranscriptional control of adipocyte differentiation through activation of phosphoinositide 3-kinase","volume":"273","author":"Sakaue","year":"1998","journal-title":"J Biol Chem"},{"key":"2022031300125947000_B5","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.cell.2012.02.030","article-title":"Systemic elevation of PTEN induces a tumor-suppressive metabolic state","volume":"149","author":"Garcia-Cao","year":"2012","journal-title":"Cell"},{"key":"2022031300125947000_B6","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.cmet.2012.02.001","article-title":"Pten positively regulates brown adipose function, energy expenditure, and longevity","volume":"15","author":"Ortega-Molina","year":"2012","journal-title":"Cell Metab"},{"key":"2022031300125947000_B7","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.cmet.2015.02.017","article-title":"Pharmacological inhibition of PI3K reduces adiposity and metabolic syndrome in obese mice and rhesus monkeys","volume":"21","author":"Ortega-Molina","year":"2015","journal-title":"Cell Metab"},{"key":"2022031300125947000_B8","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1002\/j.1460-2075.1994.tb06289.x","article-title":"PI 3-kinase: structural and functional analysis of intersubunit interactions","volume":"13","author":"Dhand","year":"1994","journal-title":"EMBO J"},{"key":"2022031300125947000_B9","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1042\/bj2880395","article-title":"Expression and characterization of the p85 subunit of the phosphatidylinositol 3-kinase complex and a related p85 beta protein by using the baculovirus expression system","volume":"288","author":"Gout","year":"1992","journal-title":"Biochem J"},{"key":"2022031300125947000_B10","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/6023","article-title":"Increased insulin sensitivity and hypoglycaemia in mice lacking the p85 alpha subunit of phosphoinositide 3-kinase","volume":"21","author":"Terauchi","year":"1999","journal-title":"Nat Genet"},{"key":"2022031300125947000_B11","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1172\/JCI0213305","article-title":"Reduced expression of the murine p85alpha subunit of phosphoinositide 3-kinase improves insulin signaling and ameliorates diabetes","volume":"109","author":"Mauvais-Jarvis","year":"2002","journal-title":"J Clin Invest"},{"key":"2022031300125947000_B12","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1073\/pnas.012581799","article-title":"Increased insulin sensitivity in mice lacking p85beta subunit of phosphoinositide 3-kinase","volume":"99","author":"Ueki","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2022031300125947000_B13","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1128\/MCB.22.3.965-977.2002","article-title":"Molecular balance between the regulatory and catalytic subunits of phosphoinositide 3-kinase regulates cell signaling and survival","volume":"22","author":"Ueki","year":"2002","journal-title":"Mol Cell Biol"},{"key":"2022031300125947000_B14","doi-asserted-by":"crossref","first-page":"10963","DOI":"10.1074\/jbc.274.16.10963","article-title":"Proliferative defect and embryonic lethality in mice homozygous for a deletion in the p110alpha subunit of phosphoinositide 3-kinase","volume":"274","author":"Bi","year":"1999","journal-title":"J Biol Chem"},{"key":"2022031300125947000_B15","first-page":"169","article-title":"Early embryonic lethality in mice deficient in the p110beta catalytic subunit of PI 3-kinase","volume":"13","author":"Bi","year":"2002","journal-title":"Mamm Genome"},{"key":"2022031300125947000_B16","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/81715","article-title":"Hypoglycaemia, liver necrosis and perinatal death in mice lacking all isoforms of phosphoinositide 3-kinase p85 alpha","volume":"26","author":"Fruman","year":"2000","journal-title":"Nat Genet"},{"key":"2022031300125947000_B17","doi-asserted-by":"crossref","first-page":"4061","DOI":"10.1158\/0008-5472.CAN-11-0549","article-title":"PIK3R1 (p85\u03b1) is somatically mutated at high frequency in primary endometrial cancer","volume":"71","author":"Urick","year":"2011","journal-title":"Cancer Res"},{"key":"2022031300125947000_B18","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.ajhg.2013.05.023","article-title":"SHORT syndrome with partial lipodystrophy due to impaired phosphatidylinositol 3 kinase signaling","volume":"93","author":"Chudasama","year":"2013","journal-title":"Am J Hum Genet"},{"key":"2022031300125947000_B19","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ajhg.2013.05.019","article-title":"PIK3R1 mutations cause syndromic insulin resistance with lipoatrophy","volume":"93","author":"Thauvin-Robinet","year":"2013","journal-title":"Am J Hum Genet"},{"key":"2022031300125947000_B20","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.ajhg.2013.06.005","article-title":"Mutations in PIK3R1 cause SHORT syndrome","volume":"93","author":"Dyment","year":"2013","journal-title":"Am J Hum Genet"},{"key":"2022031300125947000_B21","first-page":"39","article-title":"Malformation syndromes. A selected miscellany","volume":"11","author":"Gorlin","year":"1975","journal-title":"Birth Defects Orig Artic Ser"},{"key":"2022031300125947000_B22","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/ajmg.1320150104","article-title":"Autosomal dominant partial lipodystrophy associated with Rieger anomaly, short stature, and insulinopenic diabetes","volume":"15","author":"Aarskog","year":"1983","journal-title":"Am J Med Genet"},{"key":"2022031300125947000_B23","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1111\/cge.12688","article-title":"Clinical reappraisal of SHORT syndrome with PIK3R1 mutations: towards recommendation for molecular testing and management","volume":"89","author":"Avila","year":"2016","journal-title":"Clin Genet"},{"key":"2022031300125947000_B24","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1172\/JCI84005","article-title":"PI3-kinase mutation linked to insulin and growth factor resistance in vivo","volume":"126","author":"Winnay","year":"2016","journal-title":"J Clin Invest"},{"key":"2022031300125947000_B25","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/1471-2350-15-51","article-title":"Exome sequencing identifies a novel mutation in PIK3R1 as the cause of SHORT syndrome","volume":"15","author":"B\u00e1rcena","year":"2014","journal-title":"BMC Med Genet"},{"key":"2022031300125947000_B26","doi-asserted-by":"crossref","first-page":"3100","DOI":"10.1167\/iovs.16-21347","article-title":"Iris malformation and anterior segment dysgenesis in mice and humans with a mutation in PI 3-kinase","volume":"58","author":"Solheim","year":"2017","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2022031300125947000_B27","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.2337\/db11-1433","article-title":"Attenuated Pik3r1 expression prevents insulin resistance and adipose tissue macrophage accumulation in diet-induced obese mice","volume":"61","author":"McCurdy","year":"2012","journal-title":"Diabetes"},{"key":"2022031300125947000_B28","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.2337\/diabetes.53.9.2261","article-title":"Increased serum leptin protects from adiposity despite the increased glucose uptake in white adipose tissue in mice lacking p85alpha phosphoinositide 3-kinase","volume":"53","author":"Terauchi","year":"2004","journal-title":"Diabetes"},{"key":"2022031300125947000_B29","first-page":"9","article-title":"Metabolic, nutritional and endocrine studies of the hereditary obesity-diabetes syndrome of mice and mechanism of its development","volume":"2","author":"Mayer","year":"1953","journal-title":"Metabolism"},{"key":"2022031300125947000_B30","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1210\/endo-107-3-671","article-title":"A longitudinal hormonal profile of the genetically obese mouse","volume":"107","author":"Garthwaite","year":"1980","journal-title":"Endocrinology"},{"key":"2022031300125947000_B31","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/(SICI)1097-4652(199901)178:1<9::AID-JCP2>3.0.CO;2-#","article-title":"Inhibition of adipose differentiation by phosphatidylinositol 3-kinase inhibitors","volume":"178","author":"Xia","year":"1999","journal-title":"J Cell Physiol"},{"key":"2022031300125947000_B32","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1128\/MCB.21.7.2521-2532.2001","article-title":"Essential role of insulin receptor substrate 1 (IRS-1) and IRS-2 in adipocyte differentiation","volume":"21","author":"Miki","year":"2001","journal-title":"Mol Cell Biol"},{"key":"2022031300125947000_B33","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.cmet.2010.11.005","article-title":"Class IA phosphatidylinositol 3-kinase in pancreatic \u03b2 cells controls insulin secretion by multiple mechanisms","volume":"12","author":"Kaneko","year":"2010","journal-title":"Cell Metab"},{"key":"2022031300125947000_B34","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1126\/science.283.5400.393","article-title":"Impaired B cell development and proliferation in absence of phosphoinositide 3-kinase p85alpha","volume":"283","author":"Fruman","year":"1999","journal-title":"Science"},{"key":"2022031300125947000_B35","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/nri1056","article-title":"PI3K in lymphocyte development, differentiation and activation","volume":"3","author":"Okkenhaug","year":"2003","journal-title":"Nat Rev Immunol"},{"key":"2022031300125947000_B36","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/01.md.0000133625.73570.54","article-title":"Clinical course of genetic diseases of the insulin receptor (type A and Rabson-Mendenhall syndromes): a 30-year prospective","volume":"83","author":"Musso","year":"2004","journal-title":"Medicine (Baltimore)"},{"key":"2022031300125947000_B37","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1210\/jc.2006-0166","article-title":"Elevated plasma adiponectin in humans with genetically defective insulin receptors","volume":"91","author":"Semple","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"2022031300125947000_B38","first-page":"315","article-title":"Postreceptor insulin resistance contributes to human dyslipidemia and hepatic steatosis","volume":"119","author":"Semple","year":"2009","journal-title":"J Clin Invest"},{"key":"2022031300125947000_B39","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.cell.2012.02.017","article-title":"Mechanisms for insulin resistance: common threads and missing links","volume":"148","author":"Samuel","year":"2012","journal-title":"Cell"},{"key":"2022031300125947000_B40","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1194\/jlr.M023382","article-title":"Elevated TCA cycle function in the pathology of diet-induced hepatic insulin resistance and fatty liver","volume":"53","author":"Satapati","year":"2012","journal-title":"J Lipid Res"},{"key":"2022031300125947000_B41","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1053\/gast.2001.23256","article-title":"Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities","volume":"120","author":"Sanyal","year":"2001","journal-title":"Gastroenterology"}],"container-title":["Diabetes"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/diabetes.diabetesjournals.org\/syndication\/doi\/10.2337\/db17-1509","content-type":"unspecified","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.org\/diabetes\/diabetes\/article-pdf\/67\/7\/1297\/525028\/db171509.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article-pdf\/67\/7\/1297\/525028\/db171509.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,2]],"date-time":"2022-11-02T16:35:34Z","timestamp":1667406934000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article\/67\/7\/1297\/35344\/Mice-Carrying-a-Dominant-Negative-Human-PI3K"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,3]]},"references-count":41,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2018,5,3]]},"published-print":{"date-parts":[[2018,7,1]]}},"URL":"https:\/\/doi.org\/10.2337\/db17-1509","relation":{},"ISSN":["0012-1797","1939-327X"],"issn-type":[{"value":"0012-1797","type":"print"},{"value":"1939-327X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,3]]}}}